Health

An update on the first federal trial against Merck and Co. over its painkiller Vioxx, which ended in a mistrial Monday.

Continue watching

A World Health Organization initiative to provide anti-retroviral drugs to people with AIDS in low-income countries fell short of its goal of three million people by 2005. Two experts discuss the effectiveness of the initiative and the challenges of fighting…

Continue watching

In an effort to recover from major financial losses sustained by controversy over its bestselling painkiller Vioxx, drugmaker Merck & Co. announced it would cut 7,000 jobs over the next three years and close five of its manufacturing plants.

Continue reading

A report on the plight of those living without health insurance.

Continue watching

An update on the ethics troubles of a key scientist in the field of embryonic stem cell research.

Continue watching

China's Ministry of Health confirmed on Wednesday its first human cases of bird flu, heightening fears of a global flu pandemic that could kill millions. Two of the three cases in China have already killed those infected.

Continue reading

The NewsHour's health corespondent discusses the controversy behind Plan B emergency contraceptive, commonly known as the morning after pill, after the Government Accountability Office issued a report on the Food and Drug Administration's refusal to make the drug available over…

Continue watching

Health correspondent Susan Dentzer talks with Mark McClellan, administrator of the Centers for Medicare and Medicaid Services, about how to navigate the choices in Medicare's new prescription drug plan.

Continue watching

Nov. 15 is the first day to sign up for a new prescription plan under Medicare. A health unit report explains the plan designed to help seniors afford their prescriptions drugs.

Continue watching

International health experts met for three days ending Wednesday in Geneva to hammer out a global strategy against bird flu.

Continue reading